Journal Home
Search for

Volume 6, Issue 4, Pages 1278-1287 (April 2010)


View previous. 9 of 55 View next.

Highly porous bioresorbable scaffolds with controlled release of bioactive agents for tissue-regeneration applications

Orly Grinberg, Itzhak Binderman, Hila Bahar, Meital ZilbermanCorresponding Author Informationemail address

Received 10 July 2009; received in revised form 1 September 2009; accepted 28 October 2009. published online 02 November 2009.

Abstract 

Highly porous poly(dl-lactic-co-glycolic acid) films with controlled release of horseradish peroxidase (HRP) as a model protein have been successfully developed and studied. These films, which are prepared by freeze-drying inverted emulsions, are designed for use in tissue-regeneration applications. The effects of the emulsion’s formulation and host polymer’s characteristics on the film’s microstructure and HRP release profile over 4weeks were investigated. A dual pore size population is characteristic for most films, with large 12–18μm pores and small 1.5–7μm pores, and porosity in the range of 76–92%. An increase in the polymer content and its initial molecular weight, organic/aqueous (O:A) phase ratio and lactic acid content, or a decrease in the HRP content, all resulted in a decreased burst effect and a more moderate release profile. A simultaneous change in two or three of these formulation parameters (compared to a reference formulation) resulted in a synergistic effect on the HRP release profile. A constant HRP release rate was achieved when a composite film was used. Human gingival fibroblast adhesion to the films indicated good biocompatibility. Appropriate selection of the emulsion’s parameters can therefore yield highly porous films with the desired protein-release behavior which can serve as scaffolds for bioactive agents in tissue-regeneration applications.

Department of Biomedical Engineering, Faculty of Engineering, Tel-Aviv University, Tel-Aviv 69978, Israel

Corresponding Author InformationCorresponding author. Tel.: +972 3 6405842; fax: +972 3 6407939.

PII: S1742-7061(09)00482-6

doi:10.1016/j.actbio.2009.10.047


View previous. 9 of 55 View next.